A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
Not specified
Study Completion Date
September 30, 2004
Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG
Risperidone, long-acting injectable
All Listed Sponsors
collaborator
Janssen, LP
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00297388 - A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder | Biotech Hunter | Biotech Hunter